Elevation Diagnostics is now providing Covid-19 Testing Services for qualifying Businesses and Organizations

Click to see how it works

We provide full-service testing for our customers.

Here's how it works:

1. RECEIVE TEST

2. SPIT

3. SEND TO LAB FOR PROCESSING

4. RECEIVE DIGITAL RESULT

Elevation Diagnostics Covid-19 Saliva Test Kit

Covid-19 Saliva Test

FDA EUA Authorized

As effective as Nasal Swab Testing

Tests for Active Infection of Sars-Cov-2

For Asymptomatic or symptomatic baseline testing

24-48hr results after shipping to lab

Saliva is the easiest way to get tested!

Who is this test for:

This test is for organizations and businesses in need of non-invasive and reliable Covid-19 testing such as hospitals, clinics, nursing homes, universities, boarding schools, manufacturers and any high risk retail or business organizations.  Elevation Diagnostics is able to help you assess your testing needs to provide comprehensive and easy baseline testing.

How is the test administered:

Tests are delivered and can be administered by either a healthcare professional or a trained HR professional. The OM-505 device allows for easy testing of large groups of individuals. Using the overnight shipping materials, the samples are delivered to a CLIA-certified lab with results digitally available in 24-48hrs after lab receipt.  Results are available to both individuals and the representing organization and are easy to access via Elevation Diagnostic’s result portal.

Please contact us for more information:

Call or Email now to purchase tests:
Email: LAB@ELEVATIONDIAGNOSTICS.COM | Phone: 800-440-5184

EMAIL USCall Us

*This test has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. This test has not been FDA cleared or approved. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Learn more about the Emergency Use Authorization and Patient Fact Sheet